Tiragolumab
Tiragolumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Tiragolumab is under investigation in clinical trial NCT04513925 (A Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Participants With Locally Advanced, Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)).
| Trade Name | Tiragolumab |
| Generic | Tiragolumab |
| Tiragolumab Other Names | Tiragolumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Tiragolumab
